MULTICENTER PHASE II STUDY OF IMC-A12 IN PATIENTS WITH THYMOMA AND THYMIC CARCINOMA WHO HAVE BEEN PREVIOUSLY TREATED WITH CHEMOTHERAPY (NCI 8347).

Trial Profile

MULTICENTER PHASE II STUDY OF IMC-A12 IN PATIENTS WITH THYMOMA AND THYMIC CARCINOMA WHO HAVE BEEN PREVIOUSLY TREATED WITH CHEMOTHERAPY (NCI 8347).

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Cixutumumab (Primary)
  • Indications Malignant thymoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 28 May 2015 Data from 74 patients across this and 3 other trials (see CT profiles 29397, 54727 and 219237) were presented at the 2015 American Society of Clinical Oncology annual meeting.
    • 30 Mar 2012 Actual patient number 36 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top